Family Management Corp Bio Cardia, Inc. Transaction History

Family Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.87 - $2.54 $121,176 - $164,592	-64,800 Reduced 45.54%	77,500 $151,000
Q4 2022 Feb 14, 2023	BUY	$1.61 - $32.1 $183 - $3,659	114 Added 0.08%	142,300 $297,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $30.3 $34,124 - $4.31 Million	142,186 New	142,186 $276,000
Q1 2022 May 16, 2022	SELL	$21.3 - $39.0 $3.03 Million - $5.55 Million	-142,186 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$42.6 - $58.65 $6.06 Million - $8.34 Million	142,186 New	142,186 $446,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

Stay updated on Family Management Corp with notifications on news.